本页面由Tiger Trade Technology Pte. Ltd.提供服务

Belite Bio, Inc.

172.76
-8.4100-4.64%
盘后172.760.00000.00%16:17 EDT
成交量:19.90万
成交额:3,444.09万
市值:69.04亿
市盈率:-74.66
高:181.06
开:181.06
低:168.81
收:181.17
52周最高:200.00
52周最低:53.60
股本:3,996.53万
流通股本:1,938.66万
量比:1.17
换手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-2.3141
每股收益(LYR):-2.3141
净资产收益率:-16.94%
总资产收益率:-11.29%
市净率:8.96
市盈率(LYR):-74.66

数据加载中...

2024/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities